WHO ICTRP trial
Blood-brain barrier permeability and cerebral perfusion in Alzheimer*s disease
NL-OMON38302 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON38302 |
|---|---|
| Public title | Blood-brain barrier permeability and cerebral perfusion in Alzheimer*s disease |
| Scientific title | Blood-brain barrier permeability and cerebral perfusion in Alzheimer*s disease - Vascular dysfunction in AD |
| Primary sponsor | Universiteit Maastricht |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Countries | Netherlands |
| Conditions | neurodegeneratieve aandoeningen Alzheimer's disease dementia;Alzheimer's disease;dementia |
| Interventions | ;Alzheimer;blood-brain barrier;cerebral perfusion |
| Registration date | Jan 12, 2012 |
| Target size | 60 |
| Secondary IDs | NL36156.068.11 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: